High CV risk in young people is a 'delayed' crisis

Published Date: 08 Mar 2023

Cardiovascular disease is "unacceptably" high and increasing among American adults ages 20 to 44, requiring aggressive prevention.

Read Full News

Latest News

Lebrikizumab Effectively Treats AD in Patients with Skin of Color, With Vinay Mehta, MD Vinay Mehta, MD

A phase 3b study in patients with skin of color found lebrikizumab provides reliable efficacy and safety for treating moderate-to-severe AD.

Lebrikizumab Benefits AD Patients With Skin of Color, With Vinay Mehta, MD Vinay Mehta, MD

New ACAAI 2025 data show lebrikizumab improves disease control, quality of life, and work productivity in patients of skin of color with moderate to severe atopic dermatitis.

Discussing New Topical Drugs for Atopic Dermatitis in Younger Patients, With Peter Lio, MD Peter Lio, MD

This Fall Clinical Dermatology Conference interview features Peter Lio, MD, discussing takeaways from several of his sessions at the meeting.

The Medical Sisterhood: Balance and Boundaries in the Holiday Season, With Angela Lamb, MD Mona Shahriari, MD, FAAD, Angela Lamb, MD

In this episode, the topic of navigating the holiday season and balancing a thriving medical career and a fulfilling family life are highlighted.

Skin of Color Savvy: Hair-Care Challenges in Dermatology, With Amy McMichael, MD, and Kayla Taylor, MD Amy McMichael, MD, Kayla Taylor, MD

This November 18 episode explores early detection, diagnosis, and management of scarring alopecias and hair-care–related hair loss in patients of color.

Non-Steroidal Topicals: A Game-Changer for Pediatric Atopic Dermatitis, With Emily Becker, MD Emily Becker, MD

Becker recapped hot topics of discussion during a recent HCPLive clinical forum.

Todays Updates

NeuroVoices: Christina Briscoe, MD, on Improving Timely and Effective Care for Infantile Epileptic Spasm Syndrome Marco Meglio

The pediatric epileptologist at Boston Children’s Hospital discussed national variability in treating infantile epileptic spasms syndrome and the evidence gaps that continue to shape clinical decision making.

Insight the Future of Anti-Tau Drug Development for Alzheimer Disease Marco Meglio

Charles Bernick, MD, a staff neurologist at the Cleveland Clinic Lou Ruvo Center for Brain Health, commented on the scientific rationale, therapeutic strategies, and biomarker advances driving the next wave of anti-tau drug development in Alzheimer disease.

Discussing Granuloma Annulare, Lichenoid Disorders, and Social Media, With Shannon Trotter, DO

Discussing Granuloma Annulare, Lichenoid Disorders, and Social Media, With Shannon Trotter, DO

Todays Updates

NeuroVoices: Christina Briscoe, MD, on Improving Timely and Effective Care for Infantile Epileptic Spasm Syndrome Marco Meglio

The pediatric epileptologist at Boston Children’s Hospital discussed national variability in treating infantile epileptic spasms syndrome and the evidence gaps that continue to shape clinical decision making.

Insight the Future of Anti-Tau Drug Development for Alzheimer Disease Marco Meglio

Charles Bernick, MD, a staff neurologist at the Cleveland Clinic Lou Ruvo Center for Brain Health, commented on the scientific rationale, therapeutic strategies, and biomarker advances driving the next wave of anti-tau drug development in Alzheimer disease.

Discussing Granuloma Annulare, Lichenoid Disorders, and Social Media, With Shannon Trotter, DO

Discussing Granuloma Annulare, Lichenoid Disorders, and Social Media, With Shannon Trotter, DO

Latest News

A phase 3b study in patients with skin of color found lebrikizumab provides reliable efficacy and safety for treating moderate-to-severe AD.

New ACAAI 2025 data show lebrikizumab improves disease control, quality of life, and work productivity in patients of skin of color with moderate to severe atopic dermatitis.

This Fall Clinical Dermatology Conference interview features Peter Lio, MD, discussing takeaways from several of his sessions at the meeting.

In this episode, the topic of navigating the holiday season and balancing a thriving medical career and a fulfilling family life are highlighted.

This November 18 episode explores early detection, diagnosis, and management of scarring alopecias and hair-care–related hair loss in patients of color.

Becker recapped hot topics of discussion during a recent HCPLive clinical forum.

News All Time

Mid Trial Update Released on Baricitinib for Frontal Fibrosing Alopecia

Mid Trial Update Released on Baricitinib for Frontal Fibrosing Alopecia

Rezpegaldesleukin Shows Strong Phase 2b Results for Atopic Dermatitis, Asthma

Rezpegaldesleukin Shows Strong Phase 2b Results for Atopic Dermatitis, Asthma

Chronic pain may increase risk of high blood pressure in adults

Chronic pain in adults may increase their risk of high blood pressure, and the location and extent of pain and if they also had depression were contributing factors, according to new research published today in Hypertension.

Potassium-enriched salt recommended for blood pressure control

The use of potassium-enriched salt has now been recommended by the National Hypertension Taskforce—Australia's peak body for blood pressure control—in a new position statement published in the Journal of Hypertension.

New 'heart percentile' calculator helps young adults grasp their long-term risk

A new Northwestern Medicine study introduces a first-of-its-kind online calculator that uses percentiles to help younger adults forecast and understand their risk of a heart event over the next 30 years. With rates of obesity, ...

Direct link between peak air pollution and cardiac risk revealed

In Lombardy, the risk of suffering cardiac arrest may increase on days recording high levels of air pollution. This emerges from a study conducted by the Politecnico di Milano and published in the journal Global Challenges.

Hypertension affects the brain much earlier than expected, study suggests

Hypertension impairs blood vessels, neurons and white matter in the brain well before the condition causes a measurable rise in blood pressure, according to a new preclinical study from Weill Cornell Medicine investigators. ...

Common gout drug may reduce risk of heart attack and stroke

A widely used, inexpensive gout drug could reduce heart attacks and strokes in people with cardiovascular disease, according to a new review.

During a heart attack, immediate stenting of other arteries isn't always necessary

A blocked coronary artery causing an acute heart attack must be opened immediately with a stent procedure. However, if other coronary arteries also appear to be narrowed, it is safe to wait and treat those later. This approach ...

Disrupted calcium signaling can throw the heart off rhythm

A joint study by the University Medical Center Göttingen (UMG) and the University Hospital Würzburg provides new insights into why heart muscle cells lose their rhythm in atrial fibrillation. Disrupted calcium signaling ...

New pill cuts 'bad' cholesterol by 60%, potentially replacing injections

A new pill from Merck could change how millions of people treat high cholesterol and help prevent heart attacks and strokes without the need for injections.

New gene discoveries improve diagnosis of inherited heart disease

Centenary Institute researchers have uncovered new genetic causes of inherited heart conditions, providing families with vital answers to guide treatment and prevention.

From contraception to menopause: Why women face a higher risk of stroke

Stroke is one of the leading causes of disability worldwide. It places a huge burden on families, health systems and societies. Increasingly, strokes are not just occurring in older adults. They are affecting younger people ...

'Humanized' model developed to study heart valve stiffness

The first ever "humanized" model for aortic valve calcification paves the way for testing potential treatments.

Q&A: How to have a heart-healthy Thanksgiving

Thanksgiving is a time to gather with loved ones, give thanks, and savor the flavors of the season. But for anyone striving to eat heart-healthy, the holiday can present some challenges. With buttery sides, decadent desserts, ...

Very low LDL-cholesterol correlates to fewer heart problems after stroke

Brigham and Women's Hospital's TIMI Study Group reports that in patients with prior ischemic stroke, very low achieved LDL-cholesterol correlated with fewer major adverse cardiovascular events and fewer recurrent strokes, ...

Recommended News For You

Quads, Frailty, and the Future: Evolving Frontline Strategies in Multiple Myeloma

COVID Lockdowns Significantly Increasing Children's Vitamin D Deficiency?

Nuclear missile workers are contracting cancer: They blame the bases

A new device enhances liquid biopsy.

FDA Expands Approval of Osimertinib in Lung Cancer

Five-year survival in patients with unresectable hepatocellular carcinoma sets milestone

Clinical trial results show low-intensity therapy can achieve positive outcomes for certain pediatric leukemia subtypes

Recommended Articles For You

Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma 

ADCs and Bispecific Antibodies: Advancing the Future of Cancer Immunotherapy 

Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments 

Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

According to a study, male testicular cancer risk is linked to neurodevelopmental disorders.

2.

The Benefits of Exercise for Substance Use Disorders.

3.

Because of the Medicare mail-order drug rule, oncologists run the risk of self-referral violations.

4.

AI tool identifies women at high risk of interval breast cancer

5.

A pilot study investigates a novel strategy for lowering anxiety and enhancing post-stem cell transplant quality of life.

1.

Exploring the Latest Advances in PTLD Cancer Treatment

2.

Integrating Immunotherapy and Staging Guidelines in Lung Cancer Treatment

3.

The Silent Signs: Uncovering Stomach Cancer Symptoms Before It's Too Late

4.

Revolutionizing Lung Transplantation: The Promise of Donor-Specific Blood Transfusion

5.

Obesity as a major risk factor for cancer

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

2.

Efficient Management of First line ALK-rearranged NSCLC - Part III

3.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV

4.

Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment

5.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot